Cazenove Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Cazenove Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$258K	Buy	+3,050	New	+$254K	0.21%	63

Other funds holding TMO

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Eagle Capital Management (New York) New York $32.7B AUM 17.15% 1-Year Est. Return

Cazenove Capital Management's TMO Position: Q2 2013 in Review

Cazenove Capital Management opened a new position in Thermo Fisher Scientific (TMO) in Q2 2013: 3,050 shares worth $258K. The stake represents 0.21% of the portfolio and ranks #63 among its holdings.

802 funds tracked by Wall St. Rank hold TMO as of Q2 2013.

Cazenove Capital Management held 3,050 shares of Thermo Fisher Scientific worth $258K as of Q2 2013.
Thermo Fisher Scientific was a new Cazenove Capital Management position in Q2 2013.
Thermo Fisher Scientific made up 0.21% of Cazenove Capital Management's portfolio in Q2 2013, its #63 holding.
802 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2013.

Based on Cazenove Capital Management's 13F filing for Q2 2013, filed 14 Aug 2013.